Koyfin Home > Directory > Health Care > Aeglea Biothera

Aeglea Biothera Price Chart AGLE

Historical daily share price chart and data for Aeglea Biothera since 2016 adjusted for splits and dividends. The latest closing price for Aeglea Biothera as of October 23, 2020 is $7.68.
  • In 2020 the stock opened at $7.43 and closed at $7.68 for a gain of 3% YTD.
  • In 2019 the stock opened at $7.38 and closed at $7.64 for a gain of 3%.
  • In 2018 the stock opened at $5.44 and closed at $7.49 for a gain of 27%.
  • In 2017 the stock opened at $4.36 and closed at $5.41 for a gain of 19%.
View Chart On Koyfin

Aeglea Biothera Summary

Stock Symbol: AGLE

Aeglea Biothera Company Info

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients with rare genetic and cancer diseases. The company’s lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme which is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. Its preclinical pipeline products comprise ACN00177, a product candidate for the treatment of homocystinuria; AEB5100, a recombinant human enzyme that degrades plasma cystine and cysteine; AEB2109, an engineered human enzyme that targets the degradation of the amino acid methionine; and AEB3103, a product candidate. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
284.24 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of AGLE Prices